Evaluation of peripheral nerve stimulation as an alternative to radiofrequency ablation for facet joint pain

周围神经刺激替代射频消融治疗小关节疼痛的评估

基本信息

项目摘要

Project Summary It is estimated that 15% to 40% of chronic back pain cases involve the facet joints. Radiofrequency ablation (RFA) of the medial branch nerve is a widely used therapeutic intervention that is very effective in reducing facet joint pain. However, the medial branch nerve also provides motor signals to the multifidus muscle. Therefore, an unavoidable consequence of RFA is denervation of the multifidus. The multifidus muscle spans 2 to 4 spine levels, contributing significantly to the active, segmental stability of the spine. Recent reports have shown short- term adverse effects on the multifidus muscle following RFA, including multifidus atrophy and increased fat infiltration. Multifidus dysfunction causes abnormal loading and deformations of the intervertebral disc, leading to accelerated disc degeneration at the treated level. Patients also have 2 to 5 times increased risk of developing stenosis and other degenerative spine conditions or receiving a spine fusion in the 5 to 10 years after RFA, compared to other low-back pain patients. Therefore, although RFA is beneficial in the short term, it may predispose patients to other mechanisms of back pain in the future. A recently approved treatment for facet joint pain is peripheral nerve stimulation (PNS) of the medial branch. In this treatment, 1 or 2 fine‐wire leads are implanted near the medial nerve and connected to a wearable electrical stimulator. The system enables continuous delivery of electrical stimulation to the medial nerves for 40 days. After this period, the wires are removed. A recent study showed pain reduction of 70% lasting for up to 1 year, which is comparable to RFA for the medial nerve. However, the effect of PNS on the function of the multifidus muscle is known. Since the medial nerve is not damaged, it may be possible that motors signals still activate the multifidus preserving part or all its functionality. If the multifidus retains it functionality after PNS, the adverse effects observed after RFA could also be avoided. Therefore, the objective of this randomized clinical trial is to compare clinical outcomes and adverse biomechanical effects between RFA and PNS for facet joint pain. The study is divided in two aims. Aim 1 is to compare clinical and performance outcomes between RFA and PNS. Aim 2 is to quantify and compare biomechanical effects of RFA and PNS. Multifidus-sparing treatments for facet joint pain are of great interest. The multifidus muscle plays an important role in spine biomechanics. Consequently, multifidus denervation can lead to other mechanisms of spine degeneration and back pain. PNS is a promising alternative to RFA from the clinical point of view. This study will not only compare clinical outcomes between RFA and PNS, but also look at potential adverse effects in terms of spine biomechanics. If PNS doesn’t affect the multifidus function or increases the risk of spine degeneration, it can greatly change the current approach for treatment of facet joint pain.
项目摘要 据估计,15%至40%的慢性背痛病例涉及小关节。射频消融 (RFA)内侧分支神经是一种广泛使用的治疗干预, 关节痛。然而,内侧分支神经也向多裂肌提供运动信号。所以一间 RFA的不可避免的后果是多裂肌的去神经支配。多裂肌横跨2至4个脊柱 水平,显著促进脊柱的主动节段稳定性。最近的报告显示,短- RFA后对多裂肌的长期不良反应,包括多裂肌萎缩和脂肪增加 浸润多裂肌功能障碍导致椎间盘的异常负荷和变形, 加速了治疗节段的椎间盘退变。患者也有2至5倍的风险增加发展 狭窄和其他退行性脊柱疾病或在RFA后5 - 10年内接受脊柱融合, 与其他腰痛患者相比。因此,尽管RFA在短期内是有益的,但它可能 使患者在未来更容易出现其他背痛机制。 最近批准的用于小关节疼痛的治疗是内侧分支的外周神经刺激(PNS)。在 在这种治疗中,在内侧神经附近植入1根或2根细导线,并连接到可穿戴式电 刺激器该系统能够连续40天向内侧神经输送电刺激。 在此期间之后,电线被移除。最近的一项研究表明,疼痛减轻70%,持续长达1年, 这与内侧神经的RFA相当。然而,PNS对多裂肌功能的影响 肌肉是已知的。由于内侧神经没有受损,可能是运动信号仍然激活了神经元。 多裂肌保留其部分或全部功能。如果多裂肌在PNS后仍保持功能, 也可以避免RFA后观察到的影响。因此,本随机临床试验的目的是 比较RFA和PNS治疗小关节疼痛的临床结局和不良生物力学效应。的 研究分为两个目标。目的1是比较RFA和PNS的临床和性能结局。 目的2是量化和比较RFA和PNS的生物力学效应。 小关节疼痛的多裂保留治疗引起了极大的兴趣。多裂肌在 脊柱生物力学的作用。因此,多裂肌失神经支配可导致脊柱的其他机制 退化和背痛。从临床角度来看,PNS是RFA的一种有前途的替代方法。本研究将 不仅比较RFA和PNS之间的临床结局,而且还观察潜在的不良反应, 脊柱生物力学的一部分。如果PNS不影响多裂肌功能或增加脊柱退变的风险, 它可以极大地改变目前治疗小关节疼痛的方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel Humberto Cortes Correales其他文献

Daniel Humberto Cortes Correales的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel Humberto Cortes Correales', 18)}}的其他基金

Neuromuscular Electrical Stimulation for Achilles Tendon Rupture Rehabilitation
神经肌肉电刺激用于跟腱断裂康复
  • 批准号:
    10400154
  • 财政年份:
    2021
  • 资助金额:
    $ 51.42万
  • 项目类别:
Neuromuscular Electrical Stimulation for Achilles Tendon Rupture Rehabilitation
神经肌肉电刺激用于跟腱断裂康复
  • 批准号:
    10619528
  • 财政年份:
    2021
  • 资助金额:
    $ 51.42万
  • 项目类别:
continuous shear wave elastography as a diagnostic marker for tendinopathy
连续剪切波弹性成像作为肌腱病的诊断标志物
  • 批准号:
    8808800
  • 财政年份:
    2015
  • 资助金额:
    $ 51.42万
  • 项目类别:
continuous shear wave elastography as a diagnostic marker for tendinopathy
连续剪切波弹性成像作为肌腱病的诊断标志物
  • 批准号:
    9014519
  • 财政年份:
    2015
  • 资助金额:
    $ 51.42万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 51.42万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 51.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 51.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 51.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 51.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 51.42万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 51.42万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 51.42万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 51.42万
  • 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
  • 批准号:
    2706416
  • 财政年份:
    2022
  • 资助金额:
    $ 51.42万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了